Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 82.71%-13.76K | -96.74%-52.8K | 76.44%-6.93K | -148.38%-211.3K | -338.27%-75.44K | -782.44%-79.6K | 45.35%-26.84K | -202.36%-29.43K | -531.41%-85.07K | -51.39%-17.21K |
| Net income from continuing operations | 57.54%-41.99K | 25.80%-40.32K | 30.34%-35.53K | 96.85%-315.51K | 98.85%-111.26K | -273.26%-98.9K | 78.74%-54.33K | -58.48%-51.01K | -7,390.41%-10.02M | -45,684.25%-9.7M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 268.23%36.92K | 436.76%12.31K |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --9.56M | ---- |
| Other non cashItems | 36.84%9.29K | 57.61%7.14K | 20.57%5.3K | 4,616.09%139.82K | 24,724.01%124.11K | 932.23%6.79K | 630.09%4.53K | 576.68%4.4K | 98.26%-3.1K | 49.45%-504 |
| Change In working capital | 51.30%18.94K | -185.41%-19.62K | 35.57%23.3K | -110.57%-35.61K | -178.33%-88.28K | -14.01%12.52K | -88.32%22.97K | 30.94%17.19K | 1,859.87%337.06K | 1,222.05%112.71K |
| -Change in receivables | 82.16%-94 | 205.64%4.12K | -94.39%916 | 191.01%11.46K | -112.20%-426 | 10.83%-527 | 73.84%-3.9K | 2,888.72%16.31K | -250.11%-12.59K | -72.90%3.49K |
| -Change in prepaid assets | -1.35%4.01K | -0.55%4.01K | 1.26%4.02K | -95.43%25 | -7.33%-12.04K | 4.10%4.06K | 2.46%4.04K | 1.10%3.97K | 220.48%547 | -0.03%-11.22K |
| -Change in payables and accrued expense | 67.29%15.02K | -221.54%-27.75K | 693.63%18.37K | -113.49%-47.1K | -162.96%-75.82K | -20.14%8.98K | -89.00%22.83K | -131.61%-3.09K | 3,668.80%349.1K | 1,658.60%120.43K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 82.71%-13.76K | -96.74%-52.8K | 76.44%-6.93K | -148.38%-211.3K | -338.27%-75.44K | -782.44%-79.6K | 45.35%-26.84K | -202.36%-29.43K | -531.41%-85.07K | -51.39%-17.21K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -2.93%-4.85K | 4.48%-4.75K | 4.26%-4.65K | -29.00%-18.67K | -162.35%-4.13K | -1.09%-4.71K | -16.33%-4.97K | -22.50%-4.86K | 96.25%-14.48K | 69.20%-1.58K |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --3.22K | ---- |
| Net other investing changes | -2.93%-4.85K | 4.48%-4.75K | 4.26%-4.65K | -5.54%-18.67K | 13.77%-4.13K | -1.09%-4.71K | -16.33%-4.97K | -22.50%-4.86K | 95.42%-17.69K | 6.28%-4.79K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -2.93%-4.85K | 4.48%-4.75K | 4.26%-4.65K | -29.00%-18.67K | -162.35%-4.13K | -1.09%-4.71K | -16.33%-4.97K | -22.50%-4.86K | 96.25%-14.48K | 69.20%-1.58K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -77.98%18.6K | 130.49%56.47K | 11.36K | 187.98K | 79K | 84.48K | 24.5K | 0 | 0 | 0 |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net other financing activities | -77.98%18.6K | --56.47K | --11.36K | --187.98K | --79K | --84.48K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -77.98%18.6K | 130.49%56.47K | --11.36K | --187.98K | --79K | --84.48K | --24.5K | --0 | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -59.09%1.04K | -63.14%3.52K | -91.27%3.76K | -69.95%43.08K | -96.35%2.28K | -96.62%2.55K | -92.64%9.55K | -69.95%43.08K | 1,199.01%143.35K | -60.97%62.54K |
| Current changes in cash | -105.99%-10 | 85.23%-1.08K | 99.35%-224 | 57.81%-42K | 96.97%-570 | 101.22%167 | 86.30%-7.31K | -150.30%-34.28K | -176.54%-99.55K | -13.98%-18.79K |
| Effect of exchange rate changes | 222.53%533 | -538.36%-1.39K | -102.81%-21 | 472.22%2.68K | 406.74%2.05K | -168.40%-435 | 147.96%318 | 3,092.00%748 | -132.04%-720 | -60.96%-668 |
| End cash Position | -31.39%1.57K | -59.09%1.04K | -63.14%3.52K | -91.27%3.76K | -91.27%3.76K | -96.35%2.28K | -96.62%2.55K | -92.64%9.55K | -69.95%43.08K | -69.95%43.08K |
| Free cash from | 82.71%-13.76K | -96.74%-52.8K | 76.44%-6.93K | -148.38%-211.3K | -338.27%-75.44K | -782.44%-79.6K | 45.35%-26.84K | -202.36%-29.43K | -531.41%-85.07K | -51.39%-17.21K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.